Delivery Order SPE2DB20D9331-SPE2DB24FL0Q4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,595.10, is a firm fixed-price delivery order for the supply of Erythromycin 0.5% eye ointment. The contract is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,345.55, is for the delivery of ERYTHROMYCIN OPHTHALM to support the medical supply needs of military health facilities. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,786.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This award is part of the DLA's SPE2DB indefinite delivery contract (IDC), valued at up to $499,999,999, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $1,326.31 firm fixed-price delivery order is for the supply of Erythromycin Ophthalmic, a prescription eye medication, to support the recurring medical needs of U.S. military health facilities. The award is associated with a larger indefinite delivery contract (IDC) valued at up to...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,325.60 award is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams. This order is part of a larger indefinite delivery contract (IDV), contract number SPE2DB24FZR72, with a ceiling value of up to $4,999,999 that DMS Pharmaceutical Group holds with DLA to provide a broad range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $1,063.40 contract is for the delivery of Erythromycin 0.5% Eye Ointment. This order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with DLA, valued up to $4,999,999 through 2025, which enables the agency to place orders for a broad range of...
- This federal contract award, with ID SPE2DX15D9383 and SPE2DP25F5181, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $3,230.00 firm fixed-price delivery order is for the procurement of Erythromycin Ophthalmic, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,330.04 firm fixed-price contract is for the supply of Erythromycin 0.5% eye ointment 3.5g. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a...
- This federal contract award, SPE2DX15D9903|SPE2DX23FASWA, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The award, valued at $1,786.44, is for the delivery of Erythromycin ophthalmic products to the government. The prime contractor for this delivery order is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,146.10 firm fixed-price delivery order is for the supply of Erythromycin Tablets and does not have a set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB24FL0Q4Delivery Order
This federal contract award, valued at $1,860.95, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the provision of Erythromycin 0.5% eye ointment to the Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The current award is issued under this larger IDC vehicle, solidifying DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 2/8/24 |